Cargando…
Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary
Carcinomas of unknown primary (CUP) represent between 3 and 10% of malignancies. Treatment with nonspecific chemotherapy is commonly unhelpful and the median survival is between 3 and 6 months. Gene expression microarray (GEM) analysis has demonstrated that molecular signatures can aid in tumour cla...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361712/ https://www.ncbi.nlm.nih.gov/pubmed/18414470 http://dx.doi.org/10.1038/sj.bjc.6604315 |